No Data
No Data
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Craig-Hallum Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Announces Target Price $1.1
Craig-Hallum Upgrades Ironwood Pharmaceuticals(IRWD.US) to Buy Rating
Express News | Ironwood Pharmaceuticals: Do Not Plan to Make Some Apraglutide Commercial Launch Planning Investments
Ironwood Pharmaceuticals Backs 2025 Total Ironwood Rev of $260M-$290M >IRWD